FDA broadens reach of GE HealthCare’s amyloid imaging agent Vizamyl in Alzheimer’s diagnostics
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
Austin, June 27, 2025 (GLOBE NEWSWIRE) -- Companion Animal Health Market Size & Growth Analysis: According to SNS Insider, the...
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Jun 24, 2025--GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has...
Photo: Mapodile M./peopleimages.com/Adobe StockA survey conducted by Banfield Pet Hospital of 5000 pet owners across the United States looked at...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for...
Rising Pet Ownership, Increased Pet Healthcare Spending, and Growing Awareness of Pet Dental Health Drive Market Expansion Across Global Companion...
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT)...
CHICAGO--(BUSINESS WIRE)--Jun 19, 2025--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration...
Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Pet At-home Diagnostic Tests Market Size, Share & Trends Analysis Report by...